European Journal of Medicinal Chemistry p. 316 - 336 (2018)
Update date:2022-08-15
Topics:
Milik, Sandra N.
Abdel-Aziz, Amal Kamal
Lasheen, Deena S.
Serya, Rabah A.T.
Minucci, Saverio
Abouzid, Khaled A.M.
In light of the emergence of resistance against the currently available EGFR inhibitors, our study focuses on tackling this problem through the development of dual EGFR/HER2 inhibitors with improved enzymatic affinities. Guided by the binding mode of the
View MoreShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Tianjin Tongde Biological Technology Co., Ltd.
Contact:86-22-23309138
Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Doi:10.1016/0040-4020(89)80083-3
(1989)Doi:10.1021/ol4025293
(2013)Doi:10.1016/j.jorganchem.2020.121546
(2020)Doi:10.1016/j.ejmech.2010.09.016
(2010)Doi:10.1039/c39860000634
(1986)Doi:10.1016/S0040-4039(00)73263-1
(1964)